Comparison of adhesion and virulence of two predominant hospital-acquired methicillin-resistant Staphylococcus aureus clones and clonal methicillin-susceptible S. aureus isolates.
The virulence of SCCmec type IV hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates belonging to the major sequence type 8 (ST8 [Lyon clone]) and to a minor upcoming clone, ST5, was compared with that of methicillin-susceptible S. aureus (MSSA) isolates of matching sequence types. In vitro adhesion to human airway epithelial cells (HAECs) as an indicator of dissemination and mortality in a murine sepsis model as an indicator of virulence were evaluated. Ten MRSA isolates and 8 MSSA isolates of ST8 and 8 MRSA isolates and 8 MSSA isolates of ST5 were characterized with respect to multilocus sequence type; agr, spa, and capsule typing; in vitro doubling time; toxin and adhesin gene profiles; and adherence to HAECs. Adherence was significantly lower in the MRSA ST5 group than in the ST8 groups. Infections with MRSA and MSSA isolates ST8 and ST5 were compared. No change in virulence related to the presence of SCCmec was observed, since ST8 but not ST5 caused a significantly lower mortality in its presence. Despite their similar genetic backgrounds, individual clonal MRSA and MSSA isolates were heterogeneous in adherence and virulence. No one of these specific virulence factors determined in vitro was related to mouse mortality. In conclusion, in a bacteremic model, mortality was dependent on the ST and was differentially modulated by SCCmec; within an ST, clonality was not associated with a homogenous outcome.
Karauzum
Hatice
H
Department of Biomedicine, University Hospital Basel, Hebelstrasse 20, 4031 Basel, Switzerland.
Ferry
Tristan
T
de Bentzmann
Sophie
S
Lina
Gérard
G
Bes
Michèle
M
Vandenesch
François
F
Schmaler
Mathias
M
Berger-Bächi
Brigitte
B
Etienne
Jerome
J
Landmann
Regine
R
D000818:Animals; D001422:Bacterial Adhesion / Q000502:physiology*; D002999:Clone Cells; D003428:Cross Infection / Q000382:microbiology*; D004847:Epithelial Cells / Q000382:microbiology; D005838:Genotype; D006801:Humans; D008168:Lung / Q000166:cytology / Q000382:microbiology; D016106:Methicillin Resistance / Q000502:physiology*; D051379:Mice; D010641:Phenotype; D020545:Respiratory Mucosa / Q000382:microbiology; D013211:Staphylococcus aureus / Q000235:genetics* / Q000378:metabolism* / Q000472:pathogenicity*; D014774:Virulence; D037521:Virulence Factors / Q000235:genetics / Q000378:metabolism
D037521:Virulence Factors
Antimicrob Agents Chemother. 2004 Jun;48(6):2295-7
15155238
J Infect Dis. 2006 Jun 1;193(11):1495-503
16652276
J Infect Dis. 2005 Sep 1;192(5):801-10
16088829
Curr Opin Microbiol. 1999 Oct;2(5):489-93
10508723
J Antimicrob Chemother. 2002 Dec;50(6):825-31
12461000
Res Microbiol. 2004 Jun;155(5):360-9
15207868
Clin Infect Dis. 2000 Feb;30(2):368-73
10671343
J Clin Microbiol. 2006 Jul;44(7):2642-4
16825403
Antimicrob Agents Chemother. 2006 Jul;50(7):2352-60
16801412
J Immunol. 2001 Jan 1;166(1):669-77
11123352
Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):10102-7
12110733
J Clin Microbiol. 2006 Mar;44(3):847-53
16517865
J Clin Microbiol. 2008 Oct;46(10):3454-8
18667599
Epidemiol Infect. 2005 Oct;133(5):899-904
16181511
Antimicrob Agents Chemother. 2002 May;46(5):1492-502
11959587
Eur J Clin Microbiol Infect Dis. 2001 Jan;20(1):27-32
11245319
J Infect Dis. 2004 Oct 15;190(8):1506-15
15378445
J Clin Microbiol. 2007 Mar;45(3):725-9
17202275
J Infect Dis. 1981 Dec;144(6):575-82
6977003
Microbiol Immunol. 1994;38(8):599-605
7799832
Infect Control Hosp Epidemiol. 2005 Feb;26(2):166-74
15756888
Curr Infect Dis Rep. 2005 Nov;7(6):420-8
16225779
Antimicrob Agents Chemother. 2005 Jan;49(1):366-79
15616317
Infect Immun. 2005 Jun;73(6):3502-11
15908379